Rand Paul’s Congressional Review Resolution Would Overrule LDT Rule

A resolution has been introduced in the Senate to override FDA’s final rule on the regulation of laboratory-developed tests (LDTs), a move the agency hoped to avoid by speeding through the regulatory process in light of many lawmakers’ disapproval of the policy change. Sen. Rand Paul (R-KY) introduced the resolution under the Congressional Review Act (CRA) Friday (May 17). FDA finalized the rule April 29, after moving quickly to avoid the “midnight rule” period at the end of presidential terms...